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Visfatin is an adipogenic adipokine with increased levels in obesity, properties common to leptin.
Thus, leptin may modulate visfatin production in adipose tissue (AT). Therefore, we investigated
the effects of leptin on visfatin levels in 3T3-L1 adipocytes and human/murine AT, with or without
a leptin antagonist. The potential signaling pathways and mechanisms regulating visfatin pro-
duction in AT was also studied. Real-time RT-PCR and Western blotting were used to assess the
relative mRNA and protein expression of visfatin. ELISA was performed to measure visfatin levels
in conditioned media of AT explants, and small interfering RNA technology was used to reduce
leptin receptor expression. Leptin significantly (P  0.01) increased visfatin levels in human and
murine AT with a maximal response at leptin 109 M, returning to baseline at leptin 107 M.
Importantly, ip leptin administration to C57BL/6 ob/ob mice further supported leptin-induced
visfatin protein production in omental AT (P  0.05). Additionally, soluble leptin receptor levels
rose with concentration dependency to a maximal response at leptin 107 M (P 0.01). The use of
a leptin antagonist negated the induction of visfatin and soluble leptin receptor by leptin. Fur-
thermore, leptin-induced visfatin productionwas significantly decreased in the presence ofMAPK
and phosphatidylinositol 3-kinase inhibitors. Also, when the leptin receptor gene was knocked
down using small interfering RNA, leptin-induced visfatin expression was significantly decreased.
Thus, leptin increases visfatin production in AT in vivo and ex vivo via pathways involving MAPK
and phosphatidylinositol 3-kinase signaling. The pleiotropic effects of leptin may be partially
mediated by visfatin. (Endocrinology 150: 3530–3539, 2009)
Obesity, in particular visceral adiposity, has reached epi-demic proportions and is associated with serious cardio-
metabolic sequelae including insulin resistance, diabetes, dyslip-
idemia, hypertension, and cardiovascular disease, all features of
the metabolic syndrome (1). Greater understanding of the un-
derlying molecular mechanisms is required to explain the phys-
iological implications of obesity.
Apart from its role in energy storage, adipose tissue (AT)
produces several hormones and cytokines that have wide-
ranging effects on carbohydrate and lipid metabolism. These
effects play an important role in the pathogenesis of the met-
abolic syndrome (2). The expression and circulating levels of
leptin, for example, positively correlate with adiposity (3).
Besides its major roles in food intake and energy homeostasis
(4), leptin has pleiotropic effects, for example, on immunity,
angiogenesis, and reproduction (5). Also, leptin has been
shown to enhance insulin action in mouse models of obesity
and diabetes (6).
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Visfatin (pre-B cell colony-enhancing factor) is a novel adi-
pokine reported to be preferentially produced by visceral AT in
humans and mice (7). Visfatin appears to have insulin-mimetic
actions; it apparently binds to and activates the insulin receptor
at a site distinct from that of insulin (7). Visfatin has also been
shown to induce the phosphorylation of insulin receptor sub-
strate (IRS)-1, and IRS-2; binding of phosphatidylinositol
3-kinase (PI3K) to IRS-1 and IRS-2; and phosphorylation of
Akt and MAPK (7). Interestingly, leptin also phosphorylates
IRS-2 and leads to PI3K/Akt phosphorylation (8). In addition,
plasma levels of visfatin correlate positively with visceral adi-
posity (7). Furthermore, plasma concentrations of visfatin are
increased in insulin resistance states, for example, in the poly-
cysticovary syndrome (9) and type2diabetesmellitus (10).More
recently, in addition to its adipogenic potential (7), visfatin has
also been shown to promote angiogenesis (11), properties com-
mon to that of leptin.
With the aforementioned in mind, we studied the effect of
leptin on visfatin production in human and murine AT in vivo
and ex vivo and investigated the potential signaling pathways
and mechanisms regulating leptin-induced visfatin production.
Materials and Methods
Animals
Adult male C57BL/6J wild-type mice (n 48), C57BL/6 ob/ob (n
20), andC57BL/Ks db/db (n 12)micewere obtained fromHarlan Ltd.
(Loughborough,UK).Allmicewere housed individually andmaintained
under pathogen-free conditionswith controlled temperature and humid-
ity and a 12-h light (0700–1900 h), 12-h dark (1900–0700 h) cycle as
well as free access to standard mice diet and water. The standard diet
consisted of 70% carbohydrate, 10% fat, and 20% protein, with an
energy density of 3.85 kcal/g.
For in vivo experiments, adult male C57BL/6 ob/obmice (n 8; four
treated, four untreated) were used. In the treatment group, recombinant
murine leptin (PeproTech, Rocky Hill, NJ), dissolved in PBS at a con-
centration of 13mg/ml, was administered by two daily (0900–1100 and
2100–2300h) ip injectionsof5mg/kgpermouseover24h. In the control
group, twice-daily equivolume injections of PBS without leptin were
administered instead.
All animals were culled by cervical dislocation at 0900 h and sc and
omental AT were dissected and placed into sterile DMEM (Invitrogen,
Paisley, UK) for primary AT culture or immediately snap frozen in liquid
nitrogen and stored at80 C (in vivo experiments). The overall weights
for all mice used were C57BL/6J: 30  5 g; C57BL/6 ob/ob: 55  4 g;
C57BL/Ksdb/db: 535g.All procedureswere performed in accordance
with the U.K. Guidance on the Operation of Animals (Scientific Proce-
dures) Act (1986).
Subjects
After an overnight fast, omental AT samples were obtained (0800–
1000 h) from healthy subjects (n  6). Omental AT from subjects was
placed into sterile medium 199 (Sigma-Aldrich, Gillingham, UK) for
primary AT culture. The local research ethics committee approved the
study and all patients gave their informed consent, in accordance with
the guidelines inTheDeclaration ofHelsinki 2000. Exclusion criteria for
the study included known cardiovascular disease, thyroid disease, neo-
plasms, current smoking,diabetesmellitus, hypertension (bloodpressure
greater than 140/90 mm Hg), and renal impairment (serum creatinine,
120 mol/liter). None of the subjects had been prescribed any medi-
cations known to influence nutrient metabolism for at least 6 months
before the study.
Primary explant culture
AT organ explants were cultured using methods described by Fried
andMoustaid-Moussa (12).Briefly,ATwasminced into5- to10-mg [1
mm (3)] fragments, washed with a 230-m mesh (filter no. 60; Sigma-
Aldrich), and rinsedwith sterile PBSwarmed to 37C. Samples were then
transferred to six-well plates containing 3 ml DMEM (Invitrogen; mu-
rine) or media 199 (Invitrogen; human) supplemented with 50 g/ml
gentamicin and 1% fetal bovine serum (FBS; Sigma-Aldrich) and cul-
tured for 15min, 20min, or 24 hwith orwithout the addition of human/
mouse leptin (Sigma-Aldrich), leptin antagonist, i.e. recombinant leptin
triple mutant (LTM; Protein Laboratories Rehovot, Rehovot, Israel),
MAPK kinase (MEK)inhibitor (U0126; Calbiochem, San Diego, CA),
and/or PI3K inhibitor (LY294002; Calbiochem) in a 37 C incubator
under an atmosphere of 5% CO2-95% air.
Cell culture
3T3-L1 preadipocytes (American Type Culture Collection, Manassas,
VA) were cultured in DMEM (Invitrogen) containing 25 mM glucose
and 10% FBS at 37 C with 5% CO2-95% air. Two days after con-
fluence (d 0), adipocyte differentiation was induced by incubation
with DMEM, 25 mM glucose, and 10% FBS supplemented with in-
sulin (10 g/ml insulin), dexamethasone (0.25 M), rosiglitazone (10
M), and isobutylmethylxanthine (0.5 mM) until d 2. Then cells were
fed with DMEM, 25mM glucose, and 10%FBS until d 10. Before each
experiment, 3T3-L1 adipocytes were serum starved overnight in
DMEM containing 0.5% BSA.
Total RNA extraction and cDNA synthesis
Total RNA was isolated using RNeasy minikit from 3T3-L1 adipo-
cytes (QIAGEN, Crawley, UK) according to the manufacturer’s instruc-
tions. First-strand cDNA synthesis was performed using Moloney mu-
rine leukemia virus reverse transcriptase (Fermentas, York, UK) and
random hexamers (Promega, Southampton, UK) as primers.
RT-PCR
Quantitative PCR of mouse visfatin and mouse leptin receptor were
performed on a Roche Light Cycler system (RocheMolecular Biochemi-
cals,Mannheim,Germany). PCRswere carried out in a reactionmixture
consisting of 5.0 l reaction buffer and 2.0 mM MgCl2 (Biogene, Kim-
bolton, UK), 1.0 l of each primer (10 ng/l), 2.5 l cDNA, and 0.5 l
of Light Cycler DNA master SYBR Green I (Roche, Mannheim, Ger-
many). Protocol conditions consisted of denaturation of 95 C for 15 sec,
followed by 40 cycles of 94 C for 1 sec, 58 C for 10 sec, and 72 C for 12
sec, followed by melting curve analysis. For analysis, quantitative
amounts of visfatin were standardized against the housekeeping gene
-actin. The RNA levels were expressed as a ratio, using -method for
comparing relative expression results between treatments in real-time
PCR (13). The sequences of the sense and antisense primers used were:
mouse visfatin (142 bp) 5-CTTGTTCAGTCCTGGTATCC-3 and 5-
GCGAAGAGACTCCTCTGTAA-3; mouse leptin receptor (182 bp) 5-
AGGCGCAGCCTGTATTGTCC-3 and 5-CACGTTGGTGGCGAGT-
CAAG-3; and -actin (198 bp) 5-AAGAGAGGTATCCTGACCCT-3
and 5-TACATGGCTGGGTGTTGAA-3. Ten microliters of the reaction
mixture(s) were subsequently electrophoresed on a 1% agarose gel and
visualized by ethidium bromide, using a 1-kb DNA ladder (Invitrogen) to
estimate the band sizes. As a negative control for all the reactions, prepa-
rations lacking RNA or reverse transcriptase were used in place of the
cDNA. RNAs was assayed from three independent biological replicates.
Small interfering (si) RNA transfection
Chemically synthesized Stealth interference RNA siRNA directed
towardmouse leptin receptor (OB-R)wasobtained from Invitrogen.The
target sequence for siOB-R is 5-GCCUGAAGUCAUAGAUGAU-3
corresponding to the position of 495–513 relative to the start codon on
OB-R. 3T3-L1 cells were cultured and transfected with siRNA (1 M)
using Lipofectamine 2000 (Invitrogen) transfection reagent according to
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themanufacturer’s instructions. Twodays later, siRNAmediated down-
regulation of OB-R mRNA and protein levels were analyzed by quan-
titative PCR and Western blotting. A nonsilencing RNA duplex (RNA
interference explorer control siRNA duplex) was used as a negative con-
trol, according tomanufacturer’s protocol (GeneLink,Hawthorne,CA).
Sequence analysis
The PCR products from samples were purified from the 1% agarose
gel using theQIAquick gel extraction kit (QIAGEN). PCRproductswere
then sequenced in an automated DNA sequencer, and the sequence data
were analyzed using Blast nucleic acid database searches (National Cen-
tre for Biotechnology Information, Bethesda,MD), confirming the iden-
tity of our products.
Western blotting
Western blotting was used to assess: 1) leptin receptor levels in
3T3-L1 adipocytes; 2) visfatin levels in AT; 3) soluble leptin receptor
(SLR) levels in conditioned media; and 4) phospho-AKT, phospho-
Erk1/2, total AKT, and total Erk1/2 inAT. Protein lysateswere prepared
by homogenizing 3T3-L1 adipocytes or AT in radioimmunoprecipita-
tion lysis buffer (Upstate, Lake Placid, NY) according to the manufac-
turer’s instructions. Also, conditioned media of primary omental AT
culture from C57BL/6J mice were subjected to Western blotting for the
SLR.Equal amounts ofLaemmli buffer [5Murea, 0.17Msodiumdodecyl
sulfate, 0.4 M dithiothreitol, and 50mMTris-HCl (pH 8.0)] were added,
mixed, and placed in a boiling water bath for 5 min. All samples were
then allowed to cool at room temperature. The proteins in protein lysates
(35g/lane) and conditionedmedia (30l/well) were separated by SDS-
PAGE (8% resolving gel) and transferred to polyvinylidene difluoride
(PVDF) membranes at 100 V for 1 h in a transfer buffer containing 20
mM Tris, 150 mM glycine, and 20% methanol. PVDF membranes were
then blocked in Tris-buffered saline containing 0.1%Tween 20 and 5%
BSA for 2 h.
The PVDF membranes were incubated with primary rabbit-antihu-
man/antimouse antibody for visfatin (Abcam,Cambridge, UK; 1:10,000
dilution); primary rabbit-antihuman/antimouse antibody for leptin re-
ceptor (Abcam; 1:1500 dilution); primary rabbit-antihuman/antimouse
antibody for -actin (Cell Signaling Technology, Beverly, MA; 1:1000
dilution); primary rabbit-antihuman/antimouse antibody for phospho-
Erk1/2 (Cell Signaling Technology; 1:1000 dilution); primary rabbit-anti-
human/antimouse antibody for total Erk1/2 (Cell Signaling Technology;
1:1000 dilution); primary rabbit-antihuman/antimouse antibody for
phospho-AKT (Cell Signaling Technology; 1:1000 dilution); or primary
rabbit-antihuman/antimouse antibody for total AKT (Cell Signaling
Technology; 1:1000 dilution) overnight at 4 C. The membranes were
washed thoroughly for 60 min with TBS-0.1% Tween 20 before incu-
bationwith the secondary antirabbit horseradish peroxidase-conjugated
Ig (Dako, Ely, UK; 1:2000) for 1 h at room temperature. Antibody
complexes were visualized using chemiluminescence (ECL; Amer-
sham, Little Chalfont, UK). Human and mouse visfatin peptide
(Axxora, Nottingham, UK) were used as positive controls and water
as the negative control (data not shown).
ELISA analysis
Visfatin levels were determined in conditioned media from human
and mouse primary omental AT cultures, which were measured using
commercially availableEIA (EIAkit; PhoenixPharmaceuticals, Belmont,
CA; human) and ELISA (ELISA kit; MBL International, Woburn, MA;
mouse) kits, with intraassay coefficient of variations of 5.0 and 5.8%,
respectively.
Statistics
Differences between two groups were assessed using the unpaired t
test. Data involving more than two groups were assessed by ANOVA
with Bonferroni’s test for post hoc analysis. For Western immunoblot-
ting experiments, the densities were measured using a scanning den-
sitometer coupled to scanning software (ImageQuant; Molecular Dy-
namics, Amersham, Little Chalfont, UK). P  0.05 was considered
significant.
Results
Concentration-dependent effects of leptin on visfatin
mRNA expression in 3T3-L1 adipocytes
Real-time RT-PCR analysis corrected over -actin showed a
significant increase of visfatin mRNA expression by leptin in
3T3-L1 adipocytes. This was concentration dependent with a
maximal response at 109 M (Fig. 1A; P  0.05, P  0.01,
respectively), returning tobaseline values at 107M (Fig. 1A;P
0.05). Subsequent sequencing of the PCR products confirmed
gene identity.
mRNA expression and protein levels of mouse leptin
receptor (OB-R) in siOB-R transfected 3T3-L1 adipocytes
vs. control siRNA 3T3-L1 adipocytes
Real-time RT-PCR corrected over -actin and Western blot-
ting analyses showed a significant decrease of OB-R in siOB-R
transfected 3T3-L1 adipocytes compared with control 3T3-L1
adipocytes (Fig. 1, B and C; *, P 0.05, P 0.05, respectively).
Effects of leptin on visfatin mRNA expression in siOB-R
transfected 3T3-L1 adipocytes and control siRNA 3T3-L1
adipocytes
Real-time RT-PCR analysis corrected over -actin showed
that visfatin mRNA expression was significantly increased by
leptin (109 M)-treated control siRNA 3T3-L1 adipocytes when
compared with basal (control siRNA 3T3-L1 adipocytes) (Fig.
1D; ##,P 0.01). Therewere no significant differences between
basal (siOB-R transfected 3T3-L1 adipocytes) and leptin (109
M)-treated siOB-R transfected 3T3-L1 adipocytes (Fig. 1D; P
0.05). There were also no significant differences between basal
(control siRNA 3T3-L1 adipocytes) and basal (siOB-R trans-
fected 3T3-L1 adipocytes) (Fig. 1D; P 0.05). Visfatin mRNA
expression was significantly higher in leptin (109 M)-treated
control siRNA 3T3-L1 adipocytes when compared with basal
(siOB-R transfected 3T3-L1 adipocytes) as well as leptin (109 M)-
treated siOB-R transfected 3T3-L1 adipocytes (Fig. 1D; **, P
0.01, P  0.01, respectively).
Concentration-dependent effects of leptin on visfatin
protein production in C57BL/6 mouse sc and omental
AT explants
Once again, visfatin protein production was significantly in-
creased by leptin in C57BL/6 mouse omental AT explants, dose
dependently, and as before the maximal response was at 109 M
(Fig. 2A; P 0.05, P 0.01, respectively), returning to baseline
values at 107 M (Fig. 2A;P 0.05). Similar findingswere noted
in visfatin protein production by leptin in mouse subcutaneous
AT explants; however, these were not statistically significant
(data not shown). The detected protein for visfatin and -actin
had apparent molecular masses of 55 and 45 kDa, respectively
(Fig. 2A, insets).
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Concentration-dependent effects of leptin on visfatin
protein production in human omental AT explants
Like 3T3-L1 and murine AT, visfatin protein production was
significantly increasedby leptin (1011M,109M) inhumanomen-
talATexplants (Fig.2B;P0.05,P0.01,respectively).Similarly,
we noted that at a dose of leptin 107 M, visfatin net protein pro-
ductionwas significantly less than that of leptin 109 M (P 0.05)
(Fig. 2B, insets).
Effects of leptin and leptin triple mutant on leptin-
induced visfatin protein production in C57BL/6 ob/ob
and C57BL/Ks db/db mice omental AT explants
Given the above findings, we sought to investigate these ef-
fects of leptin in the leptin-deficient C57BL/6 ob/ob mouse and
the hyperleptinemic C57BL/Ks db/dbmousewith orwithout the
use of the leptin triple-mutant antagonist. Visfatin protein pro-
duction was significantly increased by leptin (1011 M, 109 M)
in C57BL/6 ob/ob mouse omental AT ex-
plants (Fig. 2C; P  0.01, P  0.001, re-
spectively) and by leptin 109M inC57BL/Ks
db/db mouse omental AT explants (Fig. 2D;
P  0.05). Also, leptin-induced visfatin pro-
teinproductionwassignificantlydecreasedby
LTM(108,107,106M) inC57BL/6ob/ob
and C57BL/Ks db/db mice omental AT ex-
plants (Fig. 2, E and F; P  0.05, P  0.01,
respectively) (Fig. 2, E and F, insets). It was
interesting to note that in these mutant mice,
once again at a higher dose of leptin (107M),
weobserved thatvisfatinproduction returned
to baseline levels (Fig. 2, C and D; P 0.05)
(Fig. 2, C and D, insets).
Concentration-dependent effects of
leptin on visfatin levels in conditioned
media
C57BL/6 mouse omental AT explants
Visfatin levels,measured byELISA,were
significantly increased by leptin (1011,
109 M) in conditioned media of C57BL/6
mouse omental AT explants (Fig. 3A; P 
0.05, P  0.01, respectively). Leptin at a
dose of 107Mhad significantly less visfatin
compared with the lower concentrations of
leptin (P  0.05).
Human omental AT explants
Visfatin levels were significantly in-
creased by leptin (1011, 109 M) in condi-
tioned media of human omental AT ex-
plants (Fig. 3B; P  0.05, P  0.01,
respectively). There was no significant dif-
ference in visfatin levels in conditioned me-
dia with leptin 107 M treatment compared
with baseline levels (Fig. 3B; P 0.05), and
levels were significantly less compared with
lower concentrations of leptin (P  0.05).
Effects of leptin and leptin triple mutant on leptin-
induced visfatin levels in conditioned media of C57BL/6
ob/ob and C57BL/Ks db/db mice omental AT explants
Visfatin levels were significantly increased by leptin (1011,
109 M) in conditionedmedia of C57BL/6 ob/obmouse omental
AT explants and by leptin 109 M in conditioned media of
C57BL/Ks db/db mouse omental AT explants (Fig. 3, C and D;
P  0.01, P  0.05, respectively). Importantly, leptin-induced
visfatin levels in conditioned media were significantly decreased
by LTM (108, 107, 106 M) in C57BL/6 ob/ob andC57BL/Ks
db/dbmice omental AT explants (Fig. 3, E and F; P 0.05, P
0.01, respectively). Again, at a leptin concentration of 107 M,
visfatin levels were significantly lower than leptin at a concen-
tration of 109 M (P 0.05), approaching baseline values (Fig.
3, C and D; P  0.05).
FIG. 1. A, Concentration-dependent effects of leptin 1011 M (L-11), leptin 1010 M (L-10), leptin 109 M (L-9),
leptin 108 M (L-8), and leptin 107 M (L-7) on visfatin mRNA expression in 3T3-L1 adipocytes at 4 h were
assessed by real-time RT-PCR, compared with basal (no supplement). Data are expressed as percent difference
of median of basal. Six independent experiments were performed and each experiment was carried out in three
replicates. Group comparison by ANOVA and post hoc Bonferroni’s test. *, P 0.05, **, P 0.01, respectively.
B, OB-R mRNA expression relative to -actin is significantly decreased in 3T3-L1 adipocytes transfected with
siOB-R compared with control siRNA, using real-time RT-PCR. Data are expressed as percent difference of
median of basal. Six independent experiments were performed and each experiment was carried out in three
replicates. Group comparison by unpaired t test. *, P 0.05. C, Leptin receptor (OB-R) protein levels relative to
-actin is significantly decreased in 3T3-L1 adipocytes transfected with siOB-R compared with control siRNA,
using Western blotting. Data are expressed as percent difference of median of basal. Six independent
experiments were performed and each experiment was carried out in three replicates. Group comparison by
unpaired t test. *, P 0.05. PSL, Phospho-stimulated light units. D, Effects of leptin on visfatin mRNA
expression in siOB-R transfected 3T3-L1 adipocytes and control siRNA 3T3-L1 adipocytes at 4 h were assessed by
real-time RT-PCR, compared with basal (no supplement). Visfatin mRNA expression was significantly increased
by leptin 109 M (L-9) in control siRNA 3T3-L1 adipocytes when compared with basal (no supplement; control
siRNA 3T3-L1 adipocytes). ##, P 0.01. Visfatin mRNA expression was significantly higher in leptin 109 M-
treated control siRNA 3T3-L1 adipocytes when compared with basal (siOB-R transfected 3T3-L1 adipocytes) as
well as leptin 109 M-treated siOB-R transfected 3T3-L1 adipocytes. **, P 0.01. Data are expressed as percent
difference of median of basal. Six independent experiments were performed and each experiment was carried
out in three replicates. Group comparison by ANOVA and post hoc Bonferroni’s test.
Endocrinology, August 2009, 150(8):3530–3539 endo.endojournals.org 3533
 at Univ of Warwick Lib - Periodicals Off on November 17, 2009 endo.endojournals.orgDownloaded from 
Effect of leptin on SLR levels in conditioned media of
C57BL/6 mouse omental AT explants
Leptin (24 h of stimulation) concentration-dependently in-
creased SLR levels in conditioned media of C57BL/6 mouse
omental AT explants.However, it was only at a concentration of
107 M that this increase was significant (Fig. 4A; P  0.01).
Similar findingswere noted after 36 and 48 h of stimulationwith
leptin, respectively (see supplemental Figs. 1 and 2, published as
FIG. 2. A and B, Concentration-dependent effects of leptin 1011 M (L-11), leptin 109 M (L-9), leptin 107 M (L-7) on visfatin protein production in C57BL/6J mouse
and human omental AT explants at 24 h were assessed by Western blotting, compared with basal (no supplement). Data are expressed as percent difference of median
of basal. Six independent experiments were performed and each experiment was carried out in three replicates. Group comparison by ANOVA and post hoc
Bonferroni’s test. *, P  0.05; **, P  0.01. PSL, Phospho-stimulated light units. C and D, Concentration-dependent effects of leptin 1011 M (L-11), leptin 109 M
(L-9), and leptin 107 M (L-7) on visfatin protein production in C57BL/6 ob/ob and C57BL/Ks db/db mouse omental AT explants at 24 h were assessed by Western
blotting, compared with basal (no supplement). Data are expressed as percent difference of median of basal. Six independent experiments were performed and each
experiment was carried out in three replicates. Group comparison by ANOVA and post hoc Bonferroni’s test. **, P  0.01; ***, P  0.001. PSL, Phospho-stimulated
light units. E and F, Concentration-dependent effects of a mouse leptin antagonist i.e. LTM on leptin-induced visfatin protein production in C57BL/6 ob/ob and C57BL/
Ks db/db mouse omental AT explants at 24 h were assessed by Western blotting, compared with leptin (109 M), without LTM. Data are expressed as percent
difference of median of basal. Six independent experiments were performed and each experiment was carried out in three replicates. Differences between groups were
assessed using the unpaired t test. *, P  0.05; **, P  0.01. PSL, Phospho-stimulated light units.
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supplemental data on The Endocrine Society’s Journals Online
web site at http://endo.endojournals.org). The detected protein
for SLR had an apparent molecular mass of 60 kDa (Fig. 4A,
inset). Also, we found that both short and long leptin receptor
levels were concentration-dependently increased by leptin
(1011, 109, and 107 M) treatments, respectively, in C57BL/6
mouse omental AT explants. However, these were not statistically
significant (data not shown). Finally, we found that the maximal
effect of leptin on SLR levels at a dose of 107 M was significantly
decreased by LTM in C57BL/6 mouse omental AT explants (Fig.
4B;P 0.05,P 0.05, andP 0.01, respectively) (Fig. 4B, inset).
Concentration-dependent effects of leptin on PI3K and
MAPK signaling pathways in C57BL/6 mouse omental
AT explants
PI3K and MAPK signaling pathways were significantly acti-
vated dose dependently by leptin in C57BL/6mouse omental AT
explants. AKT phosphorylation and Erk1/2 phosphorylation
FIG. 3. A–D, Concentration-dependent effects of leptin 1011 M (L-11), leptin 109 M (L-9), and leptin 107 M (L-7) on visfatin levels in conditioned media of C57BL/6J mouse,
human, C57BL/6 ob/obmouse, and C57BL/Ks db/dbmouse omental AT explants at 24 h were assessed by ELISA, compared with basal (no supplement). Six independent
experiments were performed and each experiment was carried out in three replicates. Group comparison by ANOVA and post hoc Bonferroni’s test. *, P 0.05, **, P 0.01.
E and F, Concentration-dependent effects of a mouse leptin antagonist i.e. LTM on leptin-induced visfatin levels in conditioned media of C57BL/6 ob/ob and C57BL/Ks db/db
mouse omental AT explants at 24 h were assessed by ELISA, compared with leptin (109 M), without LTM. Six independent experiments were performed and each experiment
was carried out in three replicates. Differences between groups were assessed using the unpaired t test. *, P 0.05; **, P 0.01; #, P 0.05; ##, 0.01.
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were significantly increased concentration dependently by leptin
in C57BL/6 mouse omental AT explants (Fig. 5, A and B: *, P
0.05, ***, P  0.001, respectively). The detected protein for
phosphorylated AKT, total AKT, phosphorylated Erk1/2 and
total Erk1/2 had apparentmolecularmasses of 44/42, 44/42, 60,
and 60 kDa, respectively (Fig. 5, A and B, insets).
Role of PI3K and MAPK signaling pathways on
leptin-induced visfatin levels
C57BL/6 mouse omental AT explants
Western blotting revealed that leptin-induced visfatin protein
production was significantly decreased by the PI3K inhibitor
(LY294002; 50 M) and the MEK inhibitor (U0126; 10 M) in
C57BL/6 mouse omental AT explants (P  0.05 and P  0.05,
respectively) (Fig. 5C, inset).
Conditionedmedia of C57BL/6mouse omental AT explants
ELISA analysis showed that leptin-induced visfatin levels
were significantly decreased by LY294002 (50 M) and U0126
(10 M) in conditioned media of C57BL/6J mouse omental AT
explants (Fig. 5D; P  0.05 and P  0.01, respectively).
Effect of ip leptin injection on visfatin protein
production in omental AT of C57BL/6 ob/ob mouse
Because leptin increased visfatin protein production in omen-
tal AT ex vivo, in particular with respect to C57BL/6 ob/ob
mouse, we administered ip leptin injections (5mg/kg per mouse)
twice daily, about 12 h apart over 24 h in C57BL/6 ob/obmice.
The leptin injections significantly increased visfatin protein pro-
duction in omental AT in these mice compared with controls
(without leptin treatments) (Fig. 6; P  0.05).
Discussion
We report here that leptin is a regulator of visfatin in human and
murine AT as well as 3T3-L1 adipocytes. Initial experiments on
3T3-L1 adipocytes revealed that leptin increased visfatinmRNA
expression concentration dependently with a maximum re-
sponse at leptin 109 M. This concentration is physiologically
relevant in both mice and humans (14, 15). Interestingly, this
effect was attenuatedwith a very high concentration of leptin. In
view of our subsequent evidence that leptin increased visfatin
protein production in omentalAT ex vivo, in particular usingAT
from C57BL/6 ob/ob mice, we administered leptin ip (5 mg/kg
per mouse) to these mice. Leptin significantly increased visfatin
protein production in omental AT in these mice compared with
controls (without leptin treatments) (Fig. 6;P 0.05).When the
leptin receptor (OB-R) gene was knocked down using siRNA,
visfatin expression significantly decreased, confirming the reg-
ulationof visfatinby leptin viaOB-R.Also, inboth subcutaneous
and omental AT of C57BL/6mice, there was a similar pattern of
leptin-induced visfatin protein production.
Given that visfatin production is greater in visceralAT (7),we
subjected omental AT from human, C57BL/6 ob/ob and
C57BL/Ks db/dbmice to leptin treatments and once again found
the same pattern of leptin-induced visfatin protein production.
The somewhat unforeseen result in C57BL/Ks db/dbmice high-
lights a possible role of the membrane bound short leptin recep-
tor (OB-Ra) in leptin-induced visfatin protein production, given
that the other membrane bound short leptin receptor isoforms
(OB-Rc, OB-Rd, OB-Rf) are not known to mediate leptin sig-
naling (5). Additionally, we measured visfatin levels in condi-
tionedmedia of all of the omental AT explants and found similar
changes in leptin-induced visfatin protein production.
The observed regulation of visfatin by leptin was further sup-
ported by studies in which omental AT of C57BL/6 ob/ob and
C57BL/Ks db/dbmice was treated with leptin in the presence of
a mouse leptin antagonist (LTM). In these studies there was a
significant concentration-dependent decrease in leptin-induced
visfatin protein production and a significant concentration-de-
pendent decrease in leptin-induced visfatin levels in conditioned
FIG. 4. A, Concentration-dependent effects of leptin 1011 M (L-11), leptin
109 M (L-9), and leptin 107 M (L-7) on SLR levels in conditioned media of
C57BL/6 mouse omental AT explants at 24 h were assessed by Western
blotting, compared with basal (no supplement). Data are expressed as
percent difference of median of basal. Six independent experiments were
performed and each experiment was carried out in three replicates. Group
comparison by ANOVA and post hoc Bonferroni’s test. **, P  0.01. PSL,
Phospho-stimulated light units. B, Concentration-dependent effects of a
mouse leptin antagonist i.e. LTM on leptin-induced SLR levels in conditioned
media of C57BL/6J mouse omental AT explants at 24 h were assessed by
Western blotting, compared with leptin (107 M), without LTM. Data are
expressed as percent difference of median of basal. Six independent
experiments were performed and each experiment was carried out in three
replicates. Differences between groups were assessed using the unpaired t
test. *, P  0.05; **, P  0.01. PSL, Phospho-stimulated light units.
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media, respectively. The precise mechanism of leptin-induced
visfatin production and regulation remains unclear.
The apparently diminished response to a very high concentra-
tion of leptin with respect to visfatin production may be partly
explained by the novel finding of significantly increased SLR levels
by leptin 107 M in conditioned media of C57BL/6J mice omental
AT explants. Furthermore, we showed that this phenomenon, sim-
ilar to the up-regulation of visfatin by leptin, was significantly de-
creased by the mouse leptin antagonist (LTM). Binding of leptin
withSLRdecreases thebioavailabilityof leptin tomembranebound
leptin receptors, and this attenuates the biological actions of leptin
(16).We also found that in omental AT explants of C57BL/6mice,
levels forboththeshortandlongleptinreceptorswerehigherduring
exposure to leptin (1011 to 107 M), although this did not achieve
statistical significance. These data are in keeping with those of Co-
hen et al. (17),who reported induction of plasma SLR levels aswell
as an increase of liver leptin receptor (both short and long) expres-
sion by leptin administration in C57BL/6 mice.
FIG. 5. A and B, Concentration-dependent effects of leptin on PI3K and MAPK signaling pathways in C57BL/6J mouse omental AT explants at 15 and 20 min,
respectively, compared with basal (B) (no supplement). Data are expressed as percent difference of median of basal. Six independent experiments were performed and
each experiment was carried out in three replicates. Group comparison by ANOVA and post hoc Bonferroni’s test. *, P  0.05; **, P  0.01. PSL, Phospho-stimulated
light units; P-AKT, phospho-Akt; P-ERK, phospho-ERK; Phos/Total, phosphorylation of the total. C, Effects of PI3K (LY294002) and MEK (U0126) inhibitors on leptin-
induced visfatin protein production in C57BL/6 mice omental AT explants at 24 h were assessed by Western blotting, compared with leptin (109 M) without inhibitors.
Data are expressed as percent difference of median of basal. Six independent experiments were performed and each experiment was carried out in three replicates.
Differences between groups were assessed using the unpaired t test. *, P  0.05. D, Effects of PI3K (LY294002) and MEK (U0126) inhibitors on leptin-induced visfatin
levels in conditioned media of C57BL/6 mice omental AT explants at 24 h were assessed by ELISA, compared with leptin (109 M) without inhibitors. Six independent
experiments were performed and each experiment was carried out in three replicates. Differences between groups were assessed using the unpaired t test. *, P  0.05;
**, P  0.01; ##, P  0.01.
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In obesity, circulating leptin (18) and visfatin (19, 20) levels
appear to be increased, although one study reported reduced
circulating visfatin levels with obesity (21). Interestingly,
Krzyzanowska et al. (22) showed that massive weight loss in
morbidly obese patients after gastroplastic surgery was accom-
panied by an increase in circulating visfatin levels.We tentatively
propose that the present data may serve to explain the apparent
paradox with visfatin levels observed in obese states, notably an
increase in soluble leptin receptors or leptin resistance in mor-
bidly obese states. The present observations reinforce the notion
that leptin, specifically free bioavailable leptin, up-regulates vis-
fatin production in AT. It is important to bear in mind that the
regulationof visfatin inAT is probablymultifactorial. In relation
to this, TNF- has recently been shown to increase levels of
visfatin in human visceral AT (23). Further studies are needed to
elucidate the role of other factors that regulate visfatin in AT.
To tease out the intracellular signaling pathways involved in
the regulation of visfatin production by leptin, we subjected
omental AT of C57BL/6 mice to leptin in the presence of inhib-
itors of MAPK and PI3K. This significantly decreased leptin-
induced visfatin protein production and decreased leptin-in-
duced visfatin levels in conditioned media. The rationale for
studying these signaling pathways was based on our observa-
tions in C57BL/Ks db/db mice [short leptin receptor (OB-Ra)
present; long leptin receptor (OB-Rb) absent], which exhibited a
dose-dependent increase in leptin-induced visfatin protein pro-
duction, albeit not as prominently as observed in C57BL/6 and
C57BL/6 ob/obmice. The MAPK and PI3K signaling pathways
are known to functionally signal throughboth the short (OB-Ra)
and long (OB-Rb) leptin receptors (8, 24). Our findings suggest
an important role of both MAPK and PI3K signaling pathways
in the regulation of visfatin production by leptin in AT. These
findings may have important implications in other tissues, i.e. in
the kidney, in which leptin signaling is maintained through the
function of the short leptin receptor, OB-Ra (25). Also, it has
recently been suggested that OB-Ra plays an important role in
the pathogenesis of nonalcoholic steatohepatitis (26), an obser-
vation that is of interest, given that the liver is another important
site of visfatin production (7).
Finally, in vivo experiments using ip leptin injections to
C57BL/6 ob/ob mice further supported leptin-induced visfatin
protein production in omental AT.
Collectively these observations suggest that the diverse ac-
tions of leptin in AT may be mediated partially by visfatin.
Equally, the various functions of visfatin may be driven, in part,
by leptin, illustrating the need for further studies. It would be of
interest to know whether the effects of leptin on visfatin pro-
duction are also applicable to other tissues. Additionally, the
present data raise the possibility of cross talk between leptin
and visfatin, possibly involving theMAPK and PI3K signaling
pathways.
In conclusion, leptin and visfatin may therefore play a coor-
dinated role in various bodily functions, including adipogenesis.
Unraveling of the varied signaling mechanisms that link leptin
with visfatin may further elucidate the pathogenesis of obesity
and associated disorders.
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